Söndag 2 November | 10:38:32 Europe / Stockholm

Prenumeration

Kalender

Est. tid*
2026-02-12 08:30 Bokslutskommuniké 2025
2025-10-21 - Kvartalsrapport 2025-Q3
2025-07-18 - Kvartalsrapport 2025-Q2
2025-05-09 - X-dag ordinarie utdelning CRAD B 0.00 SEK
2025-05-08 - Årsstämma
2025-05-07 - Kvartalsrapport 2025-Q1
2025-02-07 - Bokslutskommuniké 2024
2024-10-23 - Kvartalsrapport 2024-Q3
2024-07-18 - Kvartalsrapport 2024-Q2
2024-05-16 - X-dag ordinarie utdelning CRAD B 0.00 SEK
2024-05-15 - Årsstämma
2024-05-14 - Kvartalsrapport 2024-Q1
2024-02-08 - Bokslutskommuniké 2023
2023-10-27 - Kvartalsrapport 2023-Q3
2023-07-20 - Kvartalsrapport 2023-Q2
2023-05-08 - X-dag ordinarie utdelning CRAD B 0.00 SEK
2023-05-05 - Årsstämma
2023-05-05 - Kvartalsrapport 2023-Q1
2023-01-26 - Bokslutskommuniké 2022
2022-10-28 - Kvartalsrapport 2022-Q3
2022-07-21 - Kvartalsrapport 2022-Q2
2022-05-09 - X-dag ordinarie utdelning CRAD B 0.00 SEK
2022-05-06 - Årsstämma
2022-05-06 - Kvartalsrapport 2022-Q1
2022-01-27 - Bokslutskommuniké 2021
2021-10-28 - Kvartalsrapport 2021-Q3
2021-07-29 - Kvartalsrapport 2021-Q2
2021-05-10 - X-dag ordinarie utdelning CRAD B 0.00 SEK
2021-05-07 - Årsstämma
2021-05-07 - Kvartalsrapport 2021-Q1
2021-01-28 - Bokslutskommuniké 2020
2020-10-22 - Kvartalsrapport 2020-Q3
2020-07-31 - Kvartalsrapport 2020-Q2
2020-05-11 - X-dag ordinarie utdelning CRAD B 0.00 SEK
2020-05-08 - Årsstämma
2020-05-06 - Kvartalsrapport 2020-Q1
2020-01-31 - Bokslutskommuniké 2019
2019-12-17 - Extra Bolagsstämma 2019
2019-10-25 - Kvartalsrapport 2019-Q3
2019-08-30 - Kvartalsrapport 2019-Q2
2019-05-09 - X-dag ordinarie utdelning CRAD B 0.00 SEK
2019-05-08 - Årsstämma
2019-05-08 - Kvartalsrapport 2019-Q1
2019-02-08 - Bokslutskommuniké 2018
2018-10-26 - Kvartalsrapport 2018-Q3
2018-08-17 - Kvartalsrapport 2018-Q2
2018-05-31 - Årsstämma
2018-05-18 - X-dag ordinarie utdelning CRAD B 0.00 SEK
2018-04-26 - Kvartalsrapport 2018-Q1
2018-01-31 - Bokslutskommuniké 2017
2017-10-27 - Kvartalsrapport 2017-Q3
2017-08-16 - Kvartalsrapport 2017-Q2
2017-05-02 - X-dag ordinarie utdelning CRAD B 0.00 SEK
2017-04-28 - Årsstämma
2017-04-28 - Kvartalsrapport 2017-Q1
2017-02-13 - Bokslutskommuniké 2016
2016-11-17 - Extra Bolagsstämma 2016
2016-11-14 - Kvartalsrapport 2016-Q3
2016-08-24 - Kvartalsrapport 2016-Q2
2016-05-09 - Kvartalsrapport 2016-Q1
2016-04-15 - X-dag ordinarie utdelning CRAD B 0.00 SEK
2016-04-14 - Årsstämma
2016-02-08 - Bokslutskommuniké 2015
2015-11-06 - Kvartalsrapport 2015-Q3
2015-08-14 - Kvartalsrapport 2015-Q2
2015-05-08 - Kvartalsrapport 2015-Q1
2015-04-17 - X-dag ordinarie utdelning CRAD B 0.00 SEK
2015-04-16 - Årsstämma
2015-01-30 - Bokslutskommuniké 2014
2014-11-07 - Analytiker möte 2014
2014-11-07 - Kvartalsrapport 2014-Q3
2014-08-15 - Kvartalsrapport 2014-Q2
2014-05-16 - Kvartalsrapport 2014-Q1
2014-04-17 - X-dag ordinarie utdelning CRAD B 0.00 SEK
2014-04-16 - Årsstämma
2014-02-17 - Bokslutskommuniké 2013
2013-11-28 - Kvartalsrapport 2013-Q3
2013-11-01 - Analytiker möte 2013
2013-10-30 - Extra Bolagsstämma 2013
2013-09-02 - 15-7 2013
2013-08-30 - Kvartalsrapport 2013-Q2
2013-06-03 - X-dag ordinarie utdelning CRAD B 0.00 SEK
2013-05-31 - Årsstämma
2013-05-29 - Kvartalsrapport 2013-Q1
2013-02-26 - Bokslutskommuniké 2012
2012-12-04 - Extra Bolagsstämma 2012
2012-11-28 - Kvartalsrapport 2012-Q3
2012-09-04 - Kvartalsrapport 2012-Q2
2012-06-04 - X-dag ordinarie utdelning CRAD B 0.00 SEK
2012-06-01 - Årsstämma
2012-05-24 - Kvartalsrapport 2012-Q1
2012-02-24 - Bokslutskommuniké 2011
2011-11-25 - Kvartalsrapport 2011-Q3
2011-08-26 - Kvartalsrapport 2011-Q2
2011-05-26 - X-dag ordinarie utdelning CRAD B 0.00 SEK
2011-05-25 - Årsstämma
2011-05-24 - Kvartalsrapport 2011-Q1
2011-02-11 - Bokslutskommuniké 2010
2010-06-02 - X-dag ordinarie utdelning CRAD B 0.00 SEK
2010-06-01 - Årsstämma
2010-05-28 - Kvartalsrapport 2010-Q1
2009-11-27 - Kvartalsrapport 2009-Q3

Beskrivning

LandSverige
ListaSmall Cap Stockholm
SektorHälsovård
IndustriMedicinteknik
C-Rad är verksamt inom medicinteknikbranschen och fokuserar på utveckling och tillverkning av system för strålbehandling av cancer. Bolagets produkter riktar sig till sjukvårdsinstitutioner och onkologer. Verksamheten är närvarande på en global nivå, med huvudsaklig närvaro i Europa, Nordamerika och Asien. C-Rad grundades 2004 och har sitt huvudkontor i Uppsala.
2025-10-22 17:55:00

C-RAD AB (publ) (“C-RAD”), a global leader in surface guided radiation therapy (SGRT), announces today that the Board of Directors, supported by the authorization from the 2025 Annual General Meeting, has decided to repurchase a maximum of 597,000 class B shares for an amount of up to SEK 20 million during the period up to the 2026 Annual General Meeting (the “Repurchase Program”). The purpose of the Repurchase Program is to optimize C-RAD’s capital structure by reducing the share capital by canceling repurchased class B shares and consequently the Board of Directors of C-RAD intends to propose to the 2026 Annual General Meeting to resolve on this.

The Repurchase Program will be implemented by Pareto Securities AB on behalf of C-RAD. Pareto Securities AB will make its trading decisions regarding the B shares independently of and without influence from C-RAD and otherwise in accordance with the applicable rules and regulations of Nasdaq's rules and regulations for issuers of shares on the main market (the "Rules"), Regulation (EU) No 596/2014 of the European Parliament and of the Council on market abuse ("MAR") and Commission Delegated Regulation (EU) 2016/1052 (the "Safe Harbour Regulation").

The repurchase program is subject to the following conditions:

  • Repurchases may be made on one or more occasions during the period until the 2026 Annual General Meeting. During this period, C-RAD may repurchase a maximum of 597,000 of its own class B shares for an amount of up to 20 million SEK.
  • Repurchases shall be made on Nasdaq Stockholm and in accordance with the Rules and Regulations, MAR and the Safe Harbour Regulation.
  • Repurchases on Nasdaq Stockholm shall be made at a price per share within the price range applicable at any given time, which is the interval between the highest bid price and the lowest ask price, and in addition, the price restrictions in the Safe Harbour Regulation shall be observed.
  • Repurchases may only be made in compliance with the quantity restrictions for the purchase of own shares specified in the Rules and in the Safe Harbour Regulation.
  • In accordance with the authorization from the 2025 Annual General Meeting, C-RAD's holding of own shares may not exceed 10 percent of all outstanding shares in C-RAD.
  • Payment for the repurchase of own class B shares shall be made in cash.

The purpose of the Repurchase Program is to optimize C-RAD's capital structure by reducing the share capital with the cancellation of repurchased class B shares, and consequently the Board of Directors of C-RAD intends to propose to the 2026 Annual General Meeting to resolve on this. As previously communicated, C-RAD's financial targets, in the medium term, are for average organic growth to exceed 10 percent and the operating margin (EBIT margin) to reach 25 percent. At least 30 percent of the net profit shall be returned to shareholders.

The total number of outstanding shares is 33,766,935, divided into 862,887 class A shares and 32,904,048 class B shares. C-RAD currently holds 188,500 of its own class B shares, corresponding to approximately 0.6 percent of the total number of its own shares in C-RAD.

For further information:

Linda Frölén, acting CEO, +46 (0) 70 303 3253, investors@c-rad.com